Media

partnering

TRIANNI Signs Agreement with Massachusetts General Hospital for Use of The Trianni Mouse™ in HIV Vaccine Research

San Francisco, CA, USA, June 1 2017 – Trianni, Inc. (“TRIANNI”) announced today that it has entered into an agreement […]

Continue reading

TRIANNI and Olympic Protein Technologies Sign License Agreement for The Trianni Mouse™

San Francisco, CA and Seattle, WA, USA., May 24, 2017 –Trianni, Inc. (“TRIANNI”) and Olympic Protein Technologies (“Olympic”) jointly announced […]

Continue reading

Immunomic Therapeutics and TRIANNI Sign License Agreement for The Trianni Mouse™

Rockville, MD and San Francisco, CA, USA, May 18, 2017–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, and […]

Continue reading

Research Associate/Sr. Research Associate

We are seeking a highly self-motivated, collaborative Research Associate/Sr. Research Associate to help our team in South San Francisco with […]

Continue reading

TRIANNI Signs Agreement with Magenta Therapeutics for Use of The Trianni Mouse

San Francisco, CA, USA., March 22, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement […]

Continue reading

TRIANNI Signs Collaboration Agreement with Fred Hutchinson Cancer Research Center for use of The Trianni Mouse Platform

San Francisco, CA, USA, March 8, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has finalized a non-exclusive license agreement […]

Continue reading

GigaGen and Trianni Announce License Agreement for Discovery of Fully Human Immuno-Oncology Antibodies

Partnership leverages GigaGen’s industry-leading immune repertoire sequencing and expression technology and Trianni’s best-in-class human transgenic mouse platform. February 28, 2017– […]

Continue reading

TRIANNI Signs Agreement with Stanford University for Use of The Trianni Mouse in Vaccine Research

San Francisco, CA, USA., February 22, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement […]

Continue reading

TRIANNI Signs Licensing Agreement for Transgenic Mouse Platform Use with Janssen

San Francisco, CA, USA., February 15, 2017 –Trianni, Inc. (“TRIANNI”) announced today that it has entered into a license agreement […]

Continue reading

TRIANNI is BioWorld’s Partner in Focus

TRIANNI is featured in BioWorld Today as a Partner in Focus. Read the feature here. The feature highlights: • Advantages […]

Continue reading